Pre-operative staging of rectal cancer: a review of imaging techniques

References

• Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012, Estimated cancer incidence, mortality and prevalence worldwide. Lyon: International Agency for Research on Cancer; 2012 [cited 2014 May 11]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=colorectal
   Google Scholar
• Torre LA, Siegel RL, Ward EM, et al. Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev. 2015. doi:10.1158/1055-9965.EPI-15-0578. Epub 2015 Dec 17.
   PubMed Web of Science ®Google Scholar
• Cancer Research UK. Bowel cancer incidence statistics. 2016 [cited 2016 Jan 24]. Available from: http://www.cancerresearchuk.org/health-professional/bowel-cancer-incidence-statistics
   Google Scholar
• Iversen LH. Aspects of survival from colorectal cancer in Denmark. Dan Med J. 2012;59(4):B4428.
   PubMed Web of Science ®Google Scholar
• Cancer Research UK. Bowel cancer survival statistics. 2016 [cited 2016 Jan 24]. Available from: http://www.cancerresearchuk.org/health-professional/bowel-cancer-survival-statistics
   Google Scholar
• Wiltink LM, Chen TY, Nout RA, et al. Health-related quality of life 14years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial. Eur J Cancer. 2014. doi:10.1016/j.ejca.2014.06.020. Epub 2014 Jul 26.
   PubMed Web of Science ®Google Scholar
• MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341(8843):457–460.
   PubMed Web of Science ®Google Scholar
• Bennis M, Parc Y, Lefevre JH, et al. Morbidity risk factors after low anterior resection with total mesorectal excision and coloanal anastomosis: a retrospective series of 483 patients. Ann Surg. 2012;255(3):504–510.
   PubMed Web of Science ®Google Scholar
• Health and Social Care Information Centre. National Bowel Cancer Annual Audit Report 2013. 2013 [cited 2016 Feb 2]. Available from: http://www.hscic.gov.uk/catalogue/PUB11105/nati-clin-audi-supp-prog-bowe-canc-2013-rep1.pdf
   Google Scholar
• Health and Social Care Information Centre. National Bowel Cancer Audit Report 2015. 2015 [cited 2016 Feb 10]. Available from: http://www.hscic.gov.uk/catalogue/PUB19500/nati-clin-audi-supp-prog-bowe-canc-2015.pdf
   Google Scholar
• How P, Shihab O, Tekkis P, et al. A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol. 2011;20(4):e149–155.
   PubMed Web of Science ®Google Scholar
• Prytz M, Angenete E, Ekelund J, et al. Extralevator abdominoperineal excision (ELAPE) for rectal cancer-short-term results from the Swedish Colorectal Cancer Registry. Selective use of ELAPE warranted. Int J Colorectal Dis. 2014;29(8):981–987.
   PubMed Web of Science ®Google Scholar
• Butt HZ, Salem MK, Vijaynagar B, et al. Perineal reconstruction after extra-levator abdominoperineal excision (eLAPE): a systematic review. Int J Colorectal Dis. 2013;28(11):1459–1468.
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–646.
   PubMed Web of Science ®Google Scholar
• Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–1740.
   PubMed Web of Science ®Google Scholar
• Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93(10):1215–1223.
   PubMed Web of Science ®Google Scholar
• Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344(8924):707–711.
   PubMed Web of Science ®Google Scholar
• Kusters M, Austin KK, Solomon MJ, et al. Survival after pelvic exenteration for T4 rectal cancer. Br J Surg. 2015;102(1):125–131.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Mochizuki H, Kato T, et al. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Dis Colon Rectum. 2009;52(4):567–576.
   PubMed Web of Science ®Google Scholar
• Akasu T, Sugihara K, Moriya Y. Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol. 2009;16(10):2779–2786.
   PubMed Web of Science ®Google Scholar
• Leporrier J, Maurel J, Chiche L, et al. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006;93(4):465–474.
   PubMed Web of Science ®Google Scholar
• Baltatzis M, Chan AK, Jegatheeswaran S, et al. Colorectal cancer with synchronous hepatic metastases: systematic review of reports comparing synchronous surgery with sequential bowel-first or liver-first approaches. Eur J Surg Oncol. 2016;42(2):159–165.
   PubMed Web of Science ®Google Scholar
• Costi R, Di Mauro D, Giordano P, et al. Impact of palliative chemotherapy and surgery on management of stage IV incurable colorectal cancer. Ann Surg Oncol. 2010;17(2):432–440.
   PubMed Web of Science ®Google Scholar
• Dromain C, Caramella C, Dartigues P, et al. Liver, lung and peritoneal metastases in colorectal cancers: is the patient still curable? What should the radiologist know. Diagn Interv Imaging. 2014;95(5):513–523.
   PubMed Web of Science ®Google Scholar
• Althumairi AA, Gearhart SL. Local excision for early rectal cancer: transanal endoscopic microsurgery and beyond. J Gastrointest Oncol. 2015;6(3):296–306.
   PubMed Web of Science ®Google Scholar
• Greenberg JA, Shibata D, Herndon JE 2nd, et al. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. Dis Colon Rectum. 2008;51(8):1185–1191; discussion 1191–1184.
   PubMed Web of Science ®Google Scholar
• Habr-Gama A, Sabbaga J, Gama-Rodrigues J, et al. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum. 2013;56(10):1109–1117.
   PubMed Web of Science ®Google Scholar
• Nielsen LB, Wille-Jorgensen P. National and international guidelines for rectal cancer. Colorectal Dis. 2014;16(11):854–865.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Tiret E, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi81–88.
   PubMed Web of Science ®Google Scholar
• Salerno GV, Daniels IR, Moran BJ, et al. Magnetic resonance imaging prediction of an involved surgical resection margin in low rectal cancer. Dis Colon Rectum. 2009;52(4):632–639.
   PubMed Web of Science ®Google Scholar
• Brown G, Richards CJ, Newcombe RG, et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology. 1999;211(1):215–222.
   PubMed Web of Science ®Google Scholar
• Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 2001;357(9255):497–504.
   PubMed Web of Science ®Google Scholar
• MERCURY study group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333(7572):779.
   PubMed Web of Science ®Google Scholar
• Xie H, Zhou X, Zhuo Z, et al. Effectiveness of MRI for the assessment of mesorectal fascia involvement in patients with rectal cancer: a systematic review and meta-analysis. Dig Surg. 2014;31(2):123–134.
   PubMed Web of Science ®Google Scholar
• Taylor FGM, Quirke P, Heald RJ, et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol. 2014;32(1):34–43.
   PubMed Web of Science ®Google Scholar
• Battersby NJ, How P, Moran B, et al. Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY II study. Ann Surg. 2016;263(4):751–760.
   PubMed Web of Science ®Google Scholar
• Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19(7):2212–2223.
   PubMed Web of Science ®Google Scholar
• Waage JE, Leh S, Rosler C, et al. Endorectal ultrasonography, strain elastography and MRI differentiation of rectal adenomas and adenocarcinomas. Colorectal Dis. 2014. doi:10.1111/codi.12845. Epub 2014 Nov 20.
   Web of Science ®Google Scholar
• Bipat S, Glas AS, Slors FJ, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging–a meta-analysis. Radiology. 2004;232(3):773–783.
   PubMed Web of Science ®Google Scholar
• De Vargas Macciucca M, Casale A, Manganaro L, et al. Rectal villous tumours: MR features and correlation with TRUS in the preoperative evaluation. Eur J Radiol. 2010;73(2):329–333.
   PubMed Web of Science ®Google Scholar
• MERCURY study group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology. 2007;243(1):132–139.
   PubMed Web of Science ®Google Scholar
• Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003;227(2):371–377.
   PubMed Web of Science ®Google Scholar
• Park JS, Jang YJ, Choi GS, et al. Accuracy of preoperative MRI in predicting pathology stage in rectal cancers: node-for-node matched histopathology validation of MRI features. Dis Colon Rectum. 2014;57(1):32–38.
   PubMed Web of Science ®Google Scholar
• Heijnen LA, Lambregts DMJ, Mondal D, et al. Diffusion-weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Eur Radiol. 2013;23(12):3354–3360.
   PubMed Web of Science ®Google Scholar
• Lambregts DMJ, Maas M, Riedl RG, et al. Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study. Eur Radiol. 2011;21(2):265–273.
   PubMed Web of Science ®Google Scholar
• Koh DM, George C, Temple L, et al. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes. AJR Am J Roentgenol. 2010;194(6):W505–513.
   PubMed Web of Science ®Google Scholar
• Heijnen LA, Lambregts DMJ, Martens MH, et al. Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced? Eur Radiol. 2014;24(2):371–379.
   PubMed Web of Science ®Google Scholar
• Lambregts DMJ, Beets GL, Maas M, et al. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg. 2011;253(3):539–545.
   PubMed Web of Science ®Google Scholar
• Smith NJ, Barbachano Y, Norman AR, et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg. 2008;95(2):229–236.
   PubMed Web of Science ®Google Scholar
• Sohn B, Lim JS, Kim H, et al. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol. 2015;25(5):1347–1355.
   PubMed Web of Science ®Google Scholar
• Betge J, Pollheimer MJ, Lindtner RA, et al. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer. 2012;118(3):628–638.
   PubMed Web of Science ®Google Scholar
• Hunter CJ, Garant A, Vuong T, et al. Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment. Ann Surg Oncol. 2012;19(4):1199–1205.
   PubMed Web of Science ®Google Scholar
• Bhangu A, Ali SM, Brown G, et al. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg. 2014;259(2):315–322.
   PubMed Web of Science ®Google Scholar
• The Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013;100(8):1009–1014.
   PubMed Web of Science ®Google Scholar
• Messiou C, Chalmers AG, Boyle K, et al. Pre-operative MR assessment of recurrent rectal cancer. Br J Radiol. 2008;81(966):468–473.
   PubMed Web of Science ®Google Scholar
• Georgiou PA, Tekkis PP, Constantinides VA, et al. Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer. Eur J Cancer. 2013;49(1):72–81.
   PubMed Web of Science ®Google Scholar
• Slater A, Halligan S, Taylor SA, et al. Distance between the rectal wall and mesorectal fascia measured by MRI: effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin. Clin Radiol. 2006;61(1):65–70.
   PubMed Web of Science ®Google Scholar
• Johnson W, Taylor MB, Carrington BM, et al. The value of hyoscine butylbromide in pelvic MRI. Clin Radiol. 2007;62(11):1087–1093.
   PubMed Web of Science ®Google Scholar
• Froehlich JM, Daenzer M, von Weymarn C, et al. Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging. Eur Radiol. 2009;19(6):1387–1393.
   PubMed Web of Science ®Google Scholar
• Taylor FGM, Swift RI, Blomqvist L, et al. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol. 2008;191(6):1827–1835.
   PubMed Web of Science ®Google Scholar
• Shihab OC, Moran BJ, Heald RJ, et al. MRI staging of low rectal cancer. Eur Radiol. 2009;19(3):643–650.
   PubMed Web of Science ®Google Scholar
• Gollub MJ, Lakhman Y, McGinty K, et al. Does gadolinium-based contrast material improve diagnostic accuracy of local invasion in rectal cancer MRI? A multireader study. AJR Am J Roentgenol. 2015;204(2):W160–167.
   PubMed Web of Science ®Google Scholar
• Beets-Tan RGH, Lambregts DMJ, Maas M, et al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2013;23(9):2522–2531.
   PubMed Web of Science ®Google Scholar
• Memon S, Lynch AC, Bressel M, et al. Systematic review and meta-analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy. Colorectal Dis. 2015;17(9):748–761.
   PubMed Web of Science ®Google Scholar
• Lahaye MJ, Beets GL, Engelen SM, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology. 2009;252(1):81–91.
   PubMed Web of Science ®Google Scholar
• Koh DM, Chau I, Tait D, et al. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2008;71(2):456–461.
   PubMed Web of Science ®Google Scholar
• Yu SKT, Tait D, Chau I, et al. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy–implications for induction chemotherapy? Int J Radiat Oncol Biol Phys. 2013;87(3):505–511.
   PubMed Web of Science ®Google Scholar
• Chand M, Evans J, Swift RI, et al. The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann Surg. 2015;261(3):473–479.
   PubMed Web of Science ®Google Scholar
• Patel UB, Brown G, Rutten H, et al. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol. 2012;19(9):2842–2852.
   PubMed Web of Science ®Google Scholar
• Kim IY, Cha SW, Ahn JH, et al. Factors affecting the restaging accuracy of magnetic resonance imaging after preoperative chemoradiation in patients with rectal cancer. Eur J Surg Oncol. 2015;41(4):493–498.
   PubMed Web of Science ®Google Scholar
• Simpson GS, Eardley N, McNicol F, et al. Circumferential resection margin (CRM) positivity after MRI assessment and adjuvant treatment in 189 patients undergoing rectal cancer resection. Int J Colorectal Dis. 2014;29(5):585–590.
   PubMed Web of Science ®Google Scholar
• Pomerri F, Pucciarelli S, Maretto I, et al. Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. Surgery. 2011;149(1):56–64.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee JM, Park HS, et al. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging. 2009;29(5):1093–1101.
   PubMed Web of Science ®Google Scholar
• Barbaro B, Fiorucci C, Tebala C, et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology. 2009;250(3):730–739.
   PubMed Web of Science ®Google Scholar
• Lee NK, Kim CY, Park YJ, et al. Clinical implication of negative conversion of predicted circumferential resection margin status after preoperative chemoradiotherapy for locally advanced rectal cancer. Eur J Radiol. 2014;83(2):245–249.
   PubMed Web of Science ®Google Scholar
• Chand M, Swift RI, Tekkis PP, et al. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer. 2014;110(1):19–25.
   PubMed Web of Science ®Google Scholar
• Wu LM, Zhu J, Hu J, et al. Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer? Int J Colorectal Dis. 2013;28(9):1225–1238.
   PubMed Web of Science ®Google Scholar
• Birlik B, Obuz F, Elibol FD, et al. Diffusion-weighted MRI and MR- volumetry–in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Magn Reson Imaging. 2015;33(2):201–212.
   PubMed Web of Science ®Google Scholar
• Martens MH, Subhani S, Heijnen LA, et al. Can perfusion MRI predict response to preoperative treatment in rectal cancer? Radiother Oncol. 2015;114(2):218–223.
   PubMed Web of Science ®Google Scholar
• Petrillo A, Fusco R, Petrillo M, et al. Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC. Eur Radiol. 2015;25(7):1935–1945.
   PubMed Web of Science ®Google Scholar
• Kluza E, Rozeboom ED, Maas M, et al. T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer. Eur Radiol. 2013;23(1):253–261.
   PubMed Web of Science ®Google Scholar
• Yeo SG, Kim DY, Kim TH, et al. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2010;78(1):164–171.
   PubMed Web of Science ®Google Scholar
• Yeo S-G, Kim DY, Park JW, et al. Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2012;82(2):e193–e199.
   PubMedGoogle Scholar
• Battersby NJ, Balyasnikova S, Brown G. Guiding post-treatment decisions in rectal cancer: mrTRG is a practical place to start. Oncology (Williston Park). 2014;28(8):677–680.
   PubMed Web of Science ®Google Scholar
• Patel UB, Taylor F, Blomqvist L, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol. 2011;29(28):3753–3760.
   PubMed Web of Science ®Google Scholar
• Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology. 2010;257(3):674–684.
   PubMed Web of Science ®Google Scholar
• van Kessel CS, Buckens CFM, van den Bosch MAAJ, et al. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol. 2012;19(9):2805–2813.
   PubMed Web of Science ®Google Scholar
• Valentini V, Aristei C, Glimelius B, et al. Multidisciplinary rectal cancer management: 2nd European rectal cancer consensus conference (EURECA-CC2). Radiother Oncol. 2009;92(2):148–163.
   PubMed Web of Science ®Google Scholar
• Schmidt GP, Baur-Melnyk A, Haug A, et al. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol. 2009;19(6):1366–1378.
   PubMed Web of Science ®Google Scholar
• Huppertz A, Schmidt M, Wagner M, et al. Whole-body MR imaging versus sequential multimodal diagnostic algorithm for staging patients with rectal cancer: cost analysis. Rofo. 2010;182(9):793–802.
   PubMedGoogle Scholar
• Puli SR, Bechtold ML, Reddy JB, et al. How good is endoscopic ultrasound in differentiating various T stages of rectal cancer? Meta-analysis and systematic review. Ann Surg Oncol. 2009;16(2):254–265.
   PubMed Web of Science ®Google Scholar
• Marusch F, Ptok H, Sahm M, et al. Endorectal ultrasound in rectal carcinoma–do the literature results really correspond to the realities of routine clinical care? Endoscopy. 2011;43(5):425–431.
   PubMed Web of Science ®Google Scholar
• Waage JE, Bach SP, Pfeffer F, et al. Combined endorectal ultrasonography and strain elastography for the staging of early rectal cancer. Colorectal Dis. 2015;17(1):50–56.
   PubMed Web of Science ®Google Scholar
• Puli SR, Reddy JBK, Bechtold ML, et al. Accuracy of endoscopic ultrasound to diagnose nodal invasion by rectal cancers: a meta-analysis and systematic review. Ann Surg Oncol. 2009;16(5):1255–1265.
   PubMed Web of Science ®Google Scholar
• Swartling T, Kalebo P, Derwinger K, et al. Stage and size using magnetic resonance imaging and endosonography in neoadjuvantly-treated rectal cancer. World J Gastroenterol. 2013;19(21):3263–3271.
   PubMed Web of Science ®Google Scholar
• Rafaelsen SR, Vagn-Hansen C, Sorensen T, et al. Ultrasound elastography in patients with rectal cancer treated with chemoradiation. Eur J Radiol. 2013;82(6):913–917.
   PubMed Web of Science ®Google Scholar
• Tankova LT, Penchev PI, Kovatchki D, et al. Endosonographic assessment of rectal cancer after neoadjuvant radiotherapy. Med Ultrason. 2012;14(1):19–23.
   PubMed Web of Science ®Google Scholar
• Kocaman O, Baysal B, Senturk H, et al. Staging of rectal carcinoma: MDCT, MRI or EUS. Single center experience. Turk J Gastroenterol. 2014;25(6):669–673.
   PubMed Web of Science ®Google Scholar
• Baek SJ, Kim SH, Kwak JM, et al. Indeterminate pulmonary nodules in rectal cancer: a recommendation for follow-up guidelines. J Surg Oncol. 2012;106(4):481–485.
   PubMed Web of Science ®Google Scholar
• Kim DJ, Kim JH, Ryu YH, et al. Nodal staging of rectal cancer: high-resolution pelvic MRI versus (1)(8)F-FDGPET/CT. J Comput Assist Tomogr. 2011;35(5):531–534.
   PubMed Web of Science ®Google Scholar
• Tsunoda Y, Ito M, Fujii H, et al. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol. 2008;38(5):347–353.
   PubMed Web of Science ®Google Scholar
• Maffione AM, Lopci E, Bluemel C, et al. Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review. Eur J Nucl Med Mol Imaging. 2015;42(1):152–163.
   PubMed Web of Science ®Google Scholar
• Bamba Y, Itabashi M, Kameoka S. Value of PET/CT imaging for diagnosing pulmonary metastasis of colorectal cancer. Hepatogastroenterology. 2011;58(112):1972–1974.
   PubMed Web of Science ®Google Scholar
• Ozis SE, Soydal C, Akyol C, et al. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer. World J Surg Oncol. 2014;12:26.
   PubMed Web of Science ®Google Scholar
• Li YL, Wu LM, Chen XX, et al. Is diffusion-weighted MRI superior to FDG-PET or FDG-PET/CT in evaluating and predicting pathological response to preoperative neoadjuvant therapy in patients with rectal cancer? J Dig Dis. 2014;15(10):525–537.
   PubMed Web of Science ®Google Scholar